{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T22:51:05Z","timestamp":1761173465421,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.purol.2010.09.027","type":"journal-article","created":{"date-parts":[[2011,1,8]],"date-time":"2011-01-08T04:23:46Z","timestamp":1294460626000},"page":"245-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Actualit\u00e9s urologiques concernant les tests diagnostiques utilis\u00e9s pour les tumeurs de vessie\u00a0: le NMP22"],"prefix":"10.1016","volume":"21","author":[{"given":"F.","family":"Saint","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Quintens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Roupret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Amsellem-Ouazana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Mazerolles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Wallerand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bernardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Guy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Souli\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Pfister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.purol.2010.09.027_bib0005","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.respe.2008.03.117","article-title":"Cancer incidence and mortality in France over the period 1980\u20132005","volume":"56","author":"Belot","year":"2008","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.purol.2010.09.027_bib0010","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.purol.2008.10.025","article-title":"Prise en charge des tumeurs de vessie n\u2019infiltrant pas le muscle (TVNIM)","volume":"19","author":"Irani","year":"2009","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2010.09.027_bib0015","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S1166-7087(07)74781-4","article-title":"Recommandations 2007\u00a0en onco-urologie\u00a0: tumeurs uroth\u00e9liales","volume":"17","author":"Irani","year":"2007","journal-title":"Prog Urol"},{"issue":"4","key":"10.1016\/j.purol.2010.09.027_bib0020","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/S0022-5347(01)65569-1","article-title":"Urinary nuclear matrix protein as a marker for transitional cell carcinoma of the urinary tract","volume":"156","author":"Carpinito","year":"1996","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.purol.2010.09.027_bib0025","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0022-5347(01)63930-2","article-title":"Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder","volume":"159","author":"Stampfer","year":"1998","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.purol.2010.09.027_bib0030","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000474443","article-title":"Clinical evaluation of nuclear matrix protein 22 (NMP22) in urine as a novel marker for urothelial cancer","volume":"31","author":"Miyanaga","year":"1997","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.purol.2010.09.027_bib0035","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0090-4295(98)00219-2","article-title":"Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer","volume":"52","author":"Landman","year":"1998","journal-title":"Urology"},{"issue":"7","key":"10.1016\/j.purol.2010.09.027_bib0040","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1001\/jama.293.7.810","article-title":"Detection of bladder cancer using a point-of-care proteomic assay","volume":"293","author":"Grossman","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.purol.2010.09.027_bib0045","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0022-5347(05)66080-6","article-title":"Screening and monitoring for bladder cancer: refining the use of NMP22","volume":"166","author":"Ponsky","year":"2001","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.purol.2010.09.027_bib0050","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1464-410X.2008.07596.x","article-title":"Early results of bladder-cancer screening in a high-risk population of heavy smokers","volume":"102","author":"Steiner","year":"2008","journal-title":"BJU Int"},{"issue":"10","key":"10.1016\/j.purol.2010.09.027_bib0055","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1111\/j.1464-410X.2009.08360.x","article-title":"Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection","volume":"103","author":"Lotan","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.purol.2010.09.027_bib0060","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0022-5347(01)65851-8","article-title":"Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment","volume":"156","author":"Soloway","year":"1996","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.purol.2010.09.027_bib0065","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1464-410X.2007.07352.x","article-title":"Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma","volume":"101","author":"Hutterer","year":"2008","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.purol.2010.09.027_bib0070","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2303.2008.00586.x","article-title":"Could nuclear matrix protein 22 (NMP22) play a role with urine cytology in screening for bladder cancer?--Experience at Kuwait University","volume":"19","author":"Kapila","year":"2008","journal-title":"Cytopathology"},{"issue":"2","key":"10.1016\/j.purol.2010.09.027_bib0075","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.urology.2007.03.070","article-title":"Voided urinary cytology in bladder cancer: is it time to review the indications?","volume":"70","author":"Talwar","year":"2007","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.purol.2010.09.027_bib0080","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.urology.2008.04.051","article-title":"Nuclear matrix protein 22 as adjunct to urine cytology and cystoscopy in follow-up of superficial TCC of urinary bladder","volume":"73","author":"Gupta","year":"2009","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.purol.2010.09.027_bib0085","doi-asserted-by":"crossref","first-page":"454","DOI":"10.5489\/cuaj.1173","article-title":"NMP22 is predictive of recurrence in high-risk superficial bladder cancer patients","volume":"3","author":"Lau","year":"2009","journal-title":"Can Urol Assoc J"},{"issue":"2","key":"10.1016\/j.purol.2010.09.027_bib0090","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.eururo.2006.08.001","article-title":"Validation of the diagnostic value of NMP22 BladderChek test as a marker for bladder cancer by photodynamic diagnosis","volume":"51","author":"Tritschler","year":"2007","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.purol.2010.09.027_bib0095","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1464-410X.2008.07789.x","article-title":"The clinical utility of atypical cytology is significantly increased in both screening and monitoring for bladder cancer when indexed with nuclear matrix protein-22","volume":"102","author":"Raina","year":"2008","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.purol.2010.09.027_bib0100","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3109\/00365590903296837","article-title":"Combinations of urine-based tumour markers in bladder cancer surveillance","volume":"43","author":"Horstmann","year":"2009","journal-title":"Scand J Urol Nephrol"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708710004690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708710004690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:20:27Z","timestamp":1761114027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708710004690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S1166708710004690"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2010.09.027","relation":{},"ISSN":["1166-7087"],"issn-type":[{"type":"print","value":"1166-7087"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Actualit\u00e9s urologiques concernant les tests diagnostiques utilis\u00e9s pour les tumeurs de vessie\u00a0: le NMP22","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2010.09.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}